Articles by Liviu
-
Primum non nocere: benefits and risks of cost-effectiveness analyses for multiple myeloma treatments
Primum non nocere: benefits and risks of cost-effectiveness analyses for multiple myeloma treatments
By Liviu Niculescu, MD PhD
Activity
-
WANTED: Partner for Reverse Mentorship Family, faith and work were my father’s hierarchy of elements most important in his life. Not to discount how…
WANTED: Partner for Reverse Mentorship Family, faith and work were my father’s hierarchy of elements most important in his life. Not to discount how…
Liked by Liviu Niculescu, MD PhD
-
Happy Birthday, 21GRAMS. 🥳 And Happy 1-year Anniversary to moi. Grateful to be a part of this crew.
Happy Birthday, 21GRAMS. 🥳 And Happy 1-year Anniversary to moi. Grateful to be a part of this crew.
Liked by Liviu Niculescu, MD PhD
-
Cannes day 2 reinforced that here, media & tech brands are frenemies, competing for attention yet collaborating to draw bigger audiences than they…
Cannes day 2 reinforced that here, media & tech brands are frenemies, competing for attention yet collaborating to draw bigger audiences than they…
Liked by Liviu Niculescu, MD PhD
Experience & Education
More activity by Liviu
-
Thank you to Tom McConnell for having chaired and organized the panel "Designing an Effective Global Compliance Program" at the 2024 ILS Annual…
Thank you to Tom McConnell for having chaired and organized the panel "Designing an Effective Global Compliance Program" at the 2024 ILS Annual…
Liked by Liviu Niculescu, MD PhD
-
Overheard at Cannes Lions International Festival of Creativity “brand and performance marketing should never meet in a dark alley because brand will…
Overheard at Cannes Lions International Festival of Creativity “brand and performance marketing should never meet in a dark alley because brand will…
Liked by Liviu Niculescu, MD PhD
-
Still up, still coming! I’m proud to have continued my Chambers and Partners ranking streak alongside so many Cooley LLP colleagues. #chambers…
Still up, still coming! I’m proud to have continued my Chambers and Partners ranking streak alongside so many Cooley LLP colleagues. #chambers…
Liked by Liviu Niculescu, MD PhD
-
On April 18th, join us for an insightful Impact HR Podcast episode as Jackson Lucas' Deborah Damesek interviews Crina Pupaza, Chief People Officer at…
On April 18th, join us for an insightful Impact HR Podcast episode as Jackson Lucas' Deborah Damesek interviews Crina Pupaza, Chief People Officer at…
Liked by Liviu Niculescu, MD PhD
-
Today marks an incredible 3 years with Nymbus. From the thrill of a tech startup journey to the immense pride of winning "Best Place to Work" not…
Today marks an incredible 3 years with Nymbus. From the thrill of a tech startup journey to the immense pride of winning "Best Place to Work" not…
Liked by Liviu Niculescu, MD PhD
-
Thank you to American Chemistry Council for the opportunity to speak at this year's GlobalChem conference. I will participate in the panel on EU…
Thank you to American Chemistry Council for the opportunity to speak at this year's GlobalChem conference. I will participate in the panel on EU…
Liked by Liviu Niculescu, MD PhD
-
A Decade of Growth and Gratitude: My Farewell to Novartis As March draws to a close, I find myself reflecting on the remarkable journey that has…
A Decade of Growth and Gratitude: My Farewell to Novartis As March draws to a close, I find myself reflecting on the remarkable journey that has…
Liked by Liviu Niculescu, MD PhD
-
Thank you Prof. Sorin Costreie and UNICA Network of Universities for organizing such a great event. Proud to be able to talk about University of…
Thank you Prof. Sorin Costreie and UNICA Network of Universities for organizing such a great event. Proud to be able to talk about University of…
Liked by Liviu Niculescu, MD PhD
-
I am very excited to see Forbes recognize Nymbus as an employer of choice. This is the culmination of many decisions made along the way to build our…
I am very excited to see Forbes recognize Nymbus as an employer of choice. This is the culmination of many decisions made along the way to build our…
Liked by Liviu Niculescu, MD PhD
-
Looking forward to the next few days of presentations and discussions at IO360. Especially excited to be a part of the Women's Leadership in IO…
Looking forward to the next few days of presentations and discussions at IO360. Especially excited to be a part of the Women's Leadership in IO…
Liked by Liviu Niculescu, MD PhD
-
New York City hospitality scene is as dynamic and diverse as the city itself. In this ever-changing landscape it’s an incredible honor to be…
New York City hospitality scene is as dynamic and diverse as the city itself. In this ever-changing landscape it’s an incredible honor to be…
Liked by Liviu Niculescu, MD PhD
-
2023 was a year in which the world experienced both extraordinary challenge and immense opportunity. As it comes to a close, I’m reflecting on the…
2023 was a year in which the world experienced both extraordinary challenge and immense opportunity. As it comes to a close, I’m reflecting on the…
Liked by Liviu Niculescu, MD PhD
-
As of this month, my journey with FintechOS has come to an end. I express my gratitude to Nicolae Dinu and Dan Bratasanu for their invaluable support…
As of this month, my journey with FintechOS has come to an end. I express my gratitude to Nicolae Dinu and Dan Bratasanu for their invaluable support…
Liked by Liviu Niculescu, MD PhD
Other similar profiles
-
Juan Ovalle
Connect -
Shreeram Aradhye
Connect -
Antonio Martin MD PhD
Connect -
Paul Burton MD PhD FRCP
Chief Medical Officer at Amgen
Connect -
Zsuzsanna Devecseri MD, MBA
Connect -
Reshema Kemps-Polanco
Connect -
Desmond Creary
Connect -
Hannah Mosca
Director, Business Planning and Strategy (Chief of Staff), Novartis US Medical Affairs
Connect -
Eden Wells
Connect -
Roberta Niculescu
Third Party Risk Management Lead
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More